CRT 2023

Panel Discussion | Second- and Third-Generation Aortic Valve Systems not Approved in the US Yet

Panel Moderator(s)

• 

  Haim Danenberg, MD

  Head of interventional cardiology
  Wolfson Medical Center
  Holon, Israel

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)
• 

  Michael J. Reardon, MD

  Professor and Allison Family Distinguished Chair of Cardiovascular Research
  Houston Methodist DeBakey Heart & Vascular Center
  Houston, Texas, United States

  Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)
• 

  Toby Rogers, MD, PhD

  Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
  Georgetown University and MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): Abbott: Advisory Committee/Board Member (Ongoing); Boston Scientific: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Transmural Systems: Consultant (Ongoing), Shareholder (Ongoing)

Panel Discussant(s)

• 

  Adnan Chhatriwalla, MD

  Medical Director, Structural Intervention
  Saint Luke's Mid America Heart Institute
  Kansas City, Missouri, United States

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Proctor (Ongoing), Speakers' Bureau (Ongoing); Medtronic, Inc.: Proctor (Ongoing), Speakers' Bureau (Ongoing)
• 

  Dominic Allocco, MD, MS

  Vice President, Clinical
  Boston Scientific, Minnesota, United States

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)
• 

  Hans R. Figulla, MD, PhD

  Full Professor emeritus
  Universitätsklinikum Jena
  Jena, Thuringen, Germany

  Disclosure(s): devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)
• 

  Eberhard Grube, MD, FSCAI

  Head CIIC
  University Hospital Bonn
  Siegburg, Nordrhein-Westfalen, Germany

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)
• 

  Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

  Interventional Cardiologist
  John Muir Health Cardiovascular Institute
  San Francisco, California, United States

  Disclosure(s): AtaCor Medical: Minor stock options (Ongoing), Scientific Advisory Board (Ongoing)
• 

  Dean J. Kereiakes, MD, FACC, MSCAI

  President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
  The Christ Hospital Health Network
  Cincinnati, Ohio, United States

  Disclosure(s): Elixir Medical: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Orchestra Biomed: Consultant (Ongoing); Shockwave Medical Inc: Consultant (Ongoing); Svelte Medical: Consultant (Ongoing)
• 

  Paul D. Mahoney, MD, FACC

  Director, Structural Heart Program
  Sentara Health
  Norfolk, Virginia, United States

  Disclosure(s): No relevant disclosure to display
• 

  Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

  Professor and Clinical Director of Interventional cardiology
  Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)